2 mg tirzepatide Limited Time Offers & Promotions Tirzepatide 2.5mg: Weight Loss Starter

Quality varies by pharmacy

Mounjaro Dosage and Administration Guidelines 6

The dual GIP/GLP-1 agonist: stronger than anything else Tirzepatide is the first and so far only approved member of a new class: a dual agonist that activates two receptors at once

Common changes: Typical cumulative loss by 2 months: 818 pounds (depending on starting weight and dose) By month three, before-and-after changes are noticeable for many patients

Tirzepatide is a dual GLP-1 and GIP receptor agonist, often described as a twincretin. It is a single synthetic peptide designed to activate two incretin receptors simultaneously rather than one